Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Henlius Biotech (2696 HK)
Watchlist
109
Analysis
Health Care
•
China
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
14 Dec 2020 09:27
China Healthcare Weekly (Dec.11)
The article analyzed industry viewpoints about China ICL industry, TAVR industry and the assisted reproductive industry, and also included...
Xinyao (Criss) Wang
Follow
225 Views
Share
bullish
•
Everest Medicines
•
24 Oct 2020 23:47
What HKEX Biotech "Step-Ups" Can Tell Us
This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...
Kemp Dolliver, CFA
330 Views
Share
bullish
•
Thematic (Sector/Industry)
•
19 Oct 2020 16:46
China Healthcare Weekly (Oct.16)
This article summarized major industry viewpoints, company news, and capital market review for China healthcare industry last week.
Xinyao (Criss) Wang
Follow
243 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 Oct 2020 09:53
China Healthcare Weekly (Oct.9)
This insight summarized the important industry viewpoints, news of listed healthcare companies and capital market review for the last week of China...
Xinyao (Criss) Wang
Follow
229 Views
Share
bullish
•
Genor Biopharma Holdings
•
17 Sep 2020 01:38
JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure
$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...
Arun George
Follow
443 Views
Share
First
Previous
14
15
16
17
18
19
20
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.2
x